Related references
Note: Only part of the references are listed.EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma
Weimei Huang et al.
CANCER GENE THERAPY (2021)
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer
Jiexia Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Effect of NCOR1 Mutations on Immune Microenvironment and Efficacy of Immune Checkpoint Inhibitors in Patient with Bladder Cancer
Anqi Lin et al.
FRONTIERS IN IMMUNOLOGY (2021)
Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma
Chaozheng Zhou et al.
FRONTIERS IN IMMUNOLOGY (2021)
Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration
Rui Guan et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting the interleukin-17 immune axis for cancer immunotherapy
Gerardo A. Vitiello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
Luisa Chocarro de Erauso et al.
FRONTIERS IN PHARMACOLOGY (2020)
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
Yuchun Niu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
Anqi Lin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
Elisabet Cuyas et al.
CANCERS (2020)
Risk-Based lung cancer screening: A systematic review
Iakovos Toumazis et al.
LUNG CANCER (2020)
Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer
Anqi Lin et al.
PHARMACOLOGICAL RESEARCH (2020)
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
Yueming Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Potential predictive value of SCN4A mutation status for immune checkpoint inhibitors in melanoma
Weiyin Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Comparison of PD-L1 immunohistochemistry assays and response to PD-1/L1 inhibitors in advanced non-small-cell lung cancer in clinical practice
Liza C. Villaruz et al.
HISTOPATHOLOGY (2019)
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
David W. Vredevoogd et al.
CELL (2019)
A novel mutation panel for predicting etoposide resistance in small-cell lung cancer
Zhengang Qiu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
Anqi Lin et al.
MOLECULAR CANCER (2019)
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
Shixiang Wang et al.
ELIFE (2019)
Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: A meta-analysis
Lilan Yi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Clinicopathologic Correlation With Expression of PD-L1 on Both Tumor Cells and Tumor-infiltrating Immune Cells in Patients With Non-Small Cell Lung Cancer
Peng Song et al.
JOURNAL OF IMMUNOTHERAPY (2019)
DDR Pathway Alteration, Tumor Mutation Burden, and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole Exome and Targeted Gene Sequencing
Peng Luo et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter
Zhengang Qiu et al.
THERANOSTICS (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Min Yuen Teo et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
V. Cervera-Carrascon et al.
ONCOIMMUNOLOGY (2018)
Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade
Zhijie Wang et al.
CANCER RESEARCH (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
The efficacy and safety of ALK inhibitors in the treatment of ALK-positive non-small cell lung cancer: A network meta-analysis
Junsheng Fan et al.
CANCER MEDICINE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Human mismatch repair system balances mutation rates between strands by removing more mismatches from the lagging strand
Maria A. Andrianova et al.
GENOME RESEARCH (2017)
Targeting Immunotherapy to the Tumor Microenvironment
Michael Dougan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Predictive relevance of PD-L1 expression combined with CD8+TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
Takaaki Tokito et al.
EUROPEAN JOURNAL OF CANCER (2016)
KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer
Lihua Tong et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer
Dong-Qiang Zeng et al.
ONCOTARGET (2016)
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response
John Reiser et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
Jon Amund Kyte et al.
ONCOIMMUNOLOGY (2016)
Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC
S. A. Almatroodi et al.
CANCER MICROENVIRONMENT (2016)
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer In what state is this art?
Keith M. Kerr et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi et al.
LANCET ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy
Yanping Xiao et al.
CANCER DISCOVERY (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study
Nancy E. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumor-Infiltrating Regulatory T Cells Inhibit Endogenous Cytotoxic T Cell Responses to Lung Adenocarcinoma
Anusha-Preethi Ganesan et al.
JOURNAL OF IMMUNOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Prognostic Significance of Tumor-Infiltrating Lymphocytes for Patients With Colorectal Cancer
Jae Hyuk Lee
ARCHIVES OF SURGERY (2012)
Down-regulation of GnT-V enhances nasopharyngeal carcinoma cell CNE-2 radiosensitivity in vitro and in vivo
Enqing Zhuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation
Zhenhua Zhang et al.
CANCER BIOLOGY & THERAPY (2011)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Share Paper
